Daniel Abankwa is approaching the end of a five-year Academy of Finland Research Fellowship at the Turku Centre for Biotechnology in Finland. His group investigates how mutations to a protein called Ras can lead to cancer, and use this knowledge to develop drugs.
Sabina Siebert, Laura M. Machesky, Robert H. Insall
Interviews with senior biomedical researchers reveal a perceived decline in trust in the scientific enterprise, in large part because the quantity of new data exceeds the field's ability to process it appropriately.
